{"id":25464,"date":"2026-06-11T08:45:10","date_gmt":"2026-06-11T06:45:10","guid":{"rendered":"https:\/\/pava.eu\/?p=25464"},"modified":"2026-06-11T09:01:48","modified_gmt":"2026-06-11T07:01:48","slug":"pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical","status":"publish","type":"post","link":"https:\/\/pava.eu\/en\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\/","title":{"rendered":"Pava Partners exclusively advises contextflow&#8217;s shareholders on the sale to 4DMedical"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:calc( 1380px + 20px );margin-left: calc(-20px \/ 2 );margin-right: calc(-20px \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:20px;--awb-spacing-left-large:10px;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\"><p>Pava Partners has exclusively advised the shareholders of contextflow GmbH (&#8220;contextflow&#8221;) on the sale to 4DMedical Limited (&#8220;4DMedical&#8221;) (ASX: 4DX), a global leader in respiratory imaging technology. contextflow is an Austria-based category leader in AI-driven chest CT analysis to support radiologists in the detection of lung cancer and diagnosis of lung diseases.<\/p>\n<p>The transaction provides 4DMedical with an immediate, comprehensive, on-the-ground commercial platform in Europe, significantly accelerating its global growth strategy and establishing operations across North America, Europe and Australia.<\/p>\n<p>contextflow&#8217;s cutting-edge AI-based medical device software will complement and extend 4DMedical&#8217;s existing lung imaging portfolio, bringing structural + functional capabilities together for the first time.<\/p>\n<p><strong>contxtflow on Pava Partners<\/strong><\/p>\n<p><em>\u201ccontextflow represents a technology that is unrivalled globally \u2013 as the first and only radiology AI company with statutory health insurance reimbursement in Europe, with millions of proprietary medical imaging data points and a multi-year competitive lead. Communicating this value and guiding us throughout the competitive process with an international buyer like 4DMedical was truly valuable. We would like to thank Kevin Kissner and his team at Pava for their extraordinary commitment, their reliability, and for being by our side at every moment of the process,\u201d<\/em> says Markus Holzer, CEO and Co-founder of contextflow.<\/p>\n<\/div><div ><a class=\"fusion-button button-flat fusion-button-default-size button-custom fusion-button-default button-1 fusion-button-default-span fusion-button-default-type\" style=\"--button_accent_color:var(--awb-color1);--button_accent_hover_color:var(--awb-color3);--button_border_hover_color:var(--awb-color1);--button_gradient_top_color:var(--awb-color4);--button_gradient_bottom_color:var(--awb-color4);--button_gradient_top_color_hover:#d0d7de;--button_gradient_bottom_color_hover:#d0d7de;\" target=\"_self\" title=\"Details on the contextflow \/ 4DMedical Transaction\" aria-label=\"Details on the contextflow \/ 4DMedical Transaction\" href=\"https:\/\/pava.eu\/en\/transaktionen\/contextflow-4dmedical\/\"><span class=\"fusion-button-text awb-button__text awb-button__text--default\">Details on the contextflow \/ 4DMedical Transaction<\/span><\/a><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:30px;margin-bottom:12px;width:100%;\"><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":6,"featured_media":15950,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13],"tags":[],"kunden":[411],"sektoren":[419],"services":[420],"class_list":["post-25464","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-paptest","kunden-privatunternehmen-en","sektoren-sustainability-tech-en","services-mergers-acquisitions-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pava Partners exclusively advises contextflow&#039;s shareholders on the sale to 4DMedical - Pava Partners Germany AG<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pava.eu\/en\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pava Partners exclusively advises contextflow&#039;s shareholders on the sale to 4DMedical - Pava Partners Germany AG\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pava.eu\/en\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\/\" \/>\n<meta property=\"og:site_name\" content=\"Pava Partners Germany AG\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-11T06:45:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-11T07:01:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pava.eu\/wp-content\/uploads\/2023\/08\/pava_Flax_empty.png\" \/>\n\t<meta property=\"og:image:width\" content=\"408\" \/>\n\t<meta property=\"og:image:height\" content=\"156\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Solveig K\u00f6bernick\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Solveig K\u00f6bernick\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pava.eu\\\/en\\\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pava.eu\\\/en\\\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\\\/\"},\"author\":{\"name\":\"Solveig K\u00f6bernick\",\"@id\":\"https:\\\/\\\/pava.eu\\\/#\\\/schema\\\/person\\\/69419ef9de9210e6dbe2a64eb62d835a\"},\"headline\":\"Pava Partners exclusively advises contextflow&#8217;s shareholders on the sale to 4DMedical\",\"datePublished\":\"2026-06-11T06:45:10+00:00\",\"dateModified\":\"2026-06-11T07:01:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pava.eu\\\/en\\\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\\\/\"},\"wordCount\":1625,\"image\":{\"@id\":\"https:\\\/\\\/pava.eu\\\/en\\\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pava.eu\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/pava_Flax_empty.png\",\"articleSection\":[\"PAPtest\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pava.eu\\\/en\\\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\\\/\",\"url\":\"https:\\\/\\\/pava.eu\\\/en\\\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\\\/\",\"name\":\"Pava Partners exclusively advises contextflow's shareholders on the sale to 4DMedical - Pava Partners Germany AG\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pava.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pava.eu\\\/en\\\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pava.eu\\\/en\\\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pava.eu\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/pava_Flax_empty.png\",\"datePublished\":\"2026-06-11T06:45:10+00:00\",\"dateModified\":\"2026-06-11T07:01:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/pava.eu\\\/#\\\/schema\\\/person\\\/69419ef9de9210e6dbe2a64eb62d835a\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pava.eu\\\/en\\\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pava.eu\\\/en\\\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pava.eu\\\/en\\\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\\\/#primaryimage\",\"url\":\"https:\\\/\\\/pava.eu\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/pava_Flax_empty.png\",\"contentUrl\":\"https:\\\/\\\/pava.eu\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/pava_Flax_empty.png\",\"width\":408,\"height\":156},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pava.eu\\\/en\\\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pava.eu\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pava Partners exclusively advises contextflow&#8217;s shareholders on the sale to 4DMedical\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pava.eu\\\/#website\",\"url\":\"https:\\\/\\\/pava.eu\\\/\",\"name\":\"Pava Partners Germany AG\",\"description\":\"Financial Advisor f\u00fcr Unternehmer, Investoren und Unternehmen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pava.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pava.eu\\\/#\\\/schema\\\/person\\\/69419ef9de9210e6dbe2a64eb62d835a\",\"name\":\"Solveig K\u00f6bernick\",\"url\":\"https:\\\/\\\/pava.eu\\\/en\\\/author\\\/solveig-koebernick\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pava Partners exclusively advises contextflow's shareholders on the sale to 4DMedical - Pava Partners Germany AG","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pava.eu\/en\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\/","og_locale":"en_US","og_type":"article","og_title":"Pava Partners exclusively advises contextflow's shareholders on the sale to 4DMedical - Pava Partners Germany AG","og_url":"https:\/\/pava.eu\/en\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\/","og_site_name":"Pava Partners Germany AG","article_published_time":"2026-06-11T06:45:10+00:00","article_modified_time":"2026-06-11T07:01:48+00:00","og_image":[{"width":408,"height":156,"url":"https:\/\/pava.eu\/wp-content\/uploads\/2023\/08\/pava_Flax_empty.png","type":"image\/png"}],"author":"Solveig K\u00f6bernick","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Solveig K\u00f6bernick","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pava.eu\/en\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\/#article","isPartOf":{"@id":"https:\/\/pava.eu\/en\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\/"},"author":{"name":"Solveig K\u00f6bernick","@id":"https:\/\/pava.eu\/#\/schema\/person\/69419ef9de9210e6dbe2a64eb62d835a"},"headline":"Pava Partners exclusively advises contextflow&#8217;s shareholders on the sale to 4DMedical","datePublished":"2026-06-11T06:45:10+00:00","dateModified":"2026-06-11T07:01:48+00:00","mainEntityOfPage":{"@id":"https:\/\/pava.eu\/en\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\/"},"wordCount":1625,"image":{"@id":"https:\/\/pava.eu\/en\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\/#primaryimage"},"thumbnailUrl":"https:\/\/pava.eu\/wp-content\/uploads\/2023\/08\/pava_Flax_empty.png","articleSection":["PAPtest"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pava.eu\/en\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\/","url":"https:\/\/pava.eu\/en\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\/","name":"Pava Partners exclusively advises contextflow's shareholders on the sale to 4DMedical - Pava Partners Germany AG","isPartOf":{"@id":"https:\/\/pava.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pava.eu\/en\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\/#primaryimage"},"image":{"@id":"https:\/\/pava.eu\/en\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\/#primaryimage"},"thumbnailUrl":"https:\/\/pava.eu\/wp-content\/uploads\/2023\/08\/pava_Flax_empty.png","datePublished":"2026-06-11T06:45:10+00:00","dateModified":"2026-06-11T07:01:48+00:00","author":{"@id":"https:\/\/pava.eu\/#\/schema\/person\/69419ef9de9210e6dbe2a64eb62d835a"},"breadcrumb":{"@id":"https:\/\/pava.eu\/en\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pava.eu\/en\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pava.eu\/en\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\/#primaryimage","url":"https:\/\/pava.eu\/wp-content\/uploads\/2023\/08\/pava_Flax_empty.png","contentUrl":"https:\/\/pava.eu\/wp-content\/uploads\/2023\/08\/pava_Flax_empty.png","width":408,"height":156},{"@type":"BreadcrumbList","@id":"https:\/\/pava.eu\/en\/pava-partners-exclusively-advises-contextflows-shareholders-on-the-sale-to-4dmedical\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pava.eu\/en\/"},{"@type":"ListItem","position":2,"name":"Pava Partners exclusively advises contextflow&#8217;s shareholders on the sale to 4DMedical"}]},{"@type":"WebSite","@id":"https:\/\/pava.eu\/#website","url":"https:\/\/pava.eu\/","name":"Pava Partners Germany AG","description":"Financial Advisor f\u00fcr Unternehmer, Investoren und Unternehmen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pava.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pava.eu\/#\/schema\/person\/69419ef9de9210e6dbe2a64eb62d835a","name":"Solveig K\u00f6bernick","url":"https:\/\/pava.eu\/en\/author\/solveig-koebernick\/"}]}},"_links":{"self":[{"href":"https:\/\/pava.eu\/en\/wp-json\/wp\/v2\/posts\/25464","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pava.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pava.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pava.eu\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/pava.eu\/en\/wp-json\/wp\/v2\/comments?post=25464"}],"version-history":[{"count":5,"href":"https:\/\/pava.eu\/en\/wp-json\/wp\/v2\/posts\/25464\/revisions"}],"predecessor-version":[{"id":25493,"href":"https:\/\/pava.eu\/en\/wp-json\/wp\/v2\/posts\/25464\/revisions\/25493"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pava.eu\/en\/wp-json\/wp\/v2\/media\/15950"}],"wp:attachment":[{"href":"https:\/\/pava.eu\/en\/wp-json\/wp\/v2\/media?parent=25464"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pava.eu\/en\/wp-json\/wp\/v2\/categories?post=25464"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pava.eu\/en\/wp-json\/wp\/v2\/tags?post=25464"},{"taxonomy":"kunden","embeddable":true,"href":"https:\/\/pava.eu\/en\/wp-json\/wp\/v2\/kunden?post=25464"},{"taxonomy":"sektoren","embeddable":true,"href":"https:\/\/pava.eu\/en\/wp-json\/wp\/v2\/sektoren?post=25464"},{"taxonomy":"services","embeddable":true,"href":"https:\/\/pava.eu\/en\/wp-json\/wp\/v2\/services?post=25464"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}